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ABSTRACT 
Electron microscopic postembedding immunocytochemistry was used to analyze and assess 
the synaptic distribution of glycine (GLY) and y-amino butyric acid (GABA) immunoreactivities 
in the guinea pig cochlear nucleus (CN). Three classes of endings were identified containing 
immunolabeling for glycine, GABA, or both glycine and GABA (GLYIGABA). All classes were 
similar in that the terminals contained pleomorphic vesicles and formed symmetric synapses 
with their postsynaptic targets. A fourth class, which labeled with neither antibody, contained 
round vesicles and formed asymmetric synapses. Glycine endings predominated in the ventral 
CN, while GLYIGABA endings were prevalent in the dorsal CN. GABA endings were the least 
common and smallest in size. Glycine, GLYIGABA, and GABA endings differed in their 
proportions and patterns of distribution on the different classes of projection neurons in the 
CN, including spherical bushy, type I stellate/multipolar, and octopus cells in the ventral CN 
and fusiform cells in the dorsal CN. The vast majority of anatomically-defined, putative 
inhibitory endings contain GLY, GABA, or both, suggesting that most of the inhibition in the 
cochlear nucleus is mediated by these three cytochemically and, probably, functionally distinct 
classes of endings. The results of this study also suggest that a large proportion of the GABA 
available for inhibition in the CN coexists in terminals with glycine. 1996 ~ i ~ e y - ~ i s s ,  Inc. 
Indexing terms: auditory, immunocytochemistry, GABA, glycine, co-localization 
The amino acids glycine (GLY) and y-amino butyric acid 
(GABA) are the major chemical mediators of inhibitory 
neurotransmission in the central nervous system (Cooper 
et al., 1985; McGeer et al., 19871, and the cochlear nucleus 
(CN), which contains the second order neurons of the 
auditory pathway (reviewed by Lorente de No, 1981; Moore, 
1986; Morest, 19931, is no exception. Extensive work from 
many laboratories has provided evidence that both GABA 
and GLY are the major neurotransmitters mediating inhibi- 
tory activity in the cochlear nucleus (for reviews, see 
Godfrey et al., 1988; Altschuler et al., 1993; Caspary et al., 
1993; Evans and Zhao, 1993; Oertel and Wickesberg, 1993; 
Potashner et al., 1993). Both GABA and GLY can act via 
ionotropic receptors and provide rapid inhibitory modula- 
tion of the excitatory acoustic signal carried to CN neurons 
by auditory nerve fibers. GABA can also act via the metabo- 
tropic GABA-B receptor. 
The involvement of GABA and GLY in inhibitory neuro- 
transmission in the CN has raised questions regarding 
their cellular and synaptic localization (Wenthold, 1991). 
There have been many immunocytochemical studies of 
GABA, its biosynthetic enzyme (glutamic acid decarboxyl- 
ase, GAD), and GLY in the CN (Mugnaini, 1985; Mugnaini 
and Oertel, 1985; Shiraishi et  al., 1985; Thompson et al., 
1985; Peyret et al., 1986, 1987; Wenthold et al., 1986, 1987; 
Altschuler et al., 1986a,b, 1993; Adams and Mugnaini, 
1987; Moore and Moore, 1987; Roberts and Ribak, 1987; 
Aoki et al., 1988; Oberdorfer et al., 1988; Carr et al., 1989; 
Code and Rubel, 1989; Saint Marie et al., 1989, 1991, 1993; 
Osen et  al., 1990; Wenthold and Hunter, 1990; Kolston 
et  al., 1992; Morest, 1993). The light microscopic evalua- 
Accepted March 25,  1996 
Jose M. Juiz's present address is Department of Histology and Institute of 
Neuroscience, University of Alicante, 03580 Alicante, Spain. 
Address reprint requests to Richard A. Altschuler, Kresge Hearing 
Research Institute, The University of Michigan, 1301 East Ann, Ann Arbor, 
MI 48109-0506. 
I 1996 WILEY-LISS, INC. 
12 .J.M. JUIZ ET AI,. 
followed by an overnight wash in cold phosphate-buffered 
saline (PBS), pH 7.2-7.4. 
Transverse sections through the auditory brainstern 
were obtained at a thickness of 100 pm with a Vibratome’ 
(Oxford) and postfixed at room temperature for 1 hour ir 
0.1% osmium tetroxide in 0.1 M cacodylate buffer, pH 7.35 
Following osmication, the sections were washed in threc, 
5-minute changes of cacodylate buffer, dehydrated in graded 
ethanols, and flat embedded in epoxy resin (EMbed 81fl 
EMSciences, Fort Washington, PA). After polymerization. 
subdivisions of the CN were dissected from the sections and 
glued to blank resin blocks with a cyanoacrylate adhesive 
(Borden Wonderbond, Bordon, Columbus, OH). 
Immunogold immunocytochemistry on ultrathin sec- 
tions. Ninety-five nm serial sections were cut with ari 
ultramicrotome (Reichert Ultracut, Vienna, Austria) and 
mounted on precleaned nickel grids. They were treated 
with an  aqueous 1% sodium metaperiodate for 15 minute:; 
to remove excess osmium, rinsed in phosphate buffered 
saline (PBS), and pre-incubated for 1 hour in normal goat 
serum diluted 1:3 in a solution of 0.3% Triton X-100 in PBS 
(PBS-Triton). In a humidified chamber, grids with adjacent 
sections were incubated 24 hours at room temperature in 
antisera against GABA and GLY conjugates, diluted respec. 
tively 1:300 and 1:200 in PBS-Triton. The characteristics 
and specificity of these antibodies have been reported 
elsewhere (Wenthold et al., 1986, 1987). After a PBS rinse. 
the grids were incubated for 2 hours in goat anti-rabbit IgG 
conjugated to 15 nm colloidal gold particles (Auroprobe 
GAR15, Janssen Pharmaceutica, Piscataway, NJ), diluted 
1 : l O  in PBS-Triton. Following distilled water rinses, the sec- 
tions were counterstained with lead citrate and examined with 
a JEOL EM-1200 electron microscope equipped with a double 
grid specimen holder to facilitate the study of serial sections. 
Evaluation of immunogold immunolabeling. Synaptic 
endings, axons, or cell bodies were considered immunola- 
beled whenever an  unequivocally large accumulation of 
gold particles was evident over these structures. Accumula- 
tion of gold particles on tissue areas judged as non-labeled 
(‘background labeling’) had at least 3-4 times lower density 
than labeled terminals, and accumulation was virtually 
absent from regions of empty resin, which permitted subjec- 
tive evaluation of immunolabeling. 
Subjective patterns of GABA 
and GLY immunolabeling were confirmed from electron 
micrographs by calculating the average density of gold 
particles on a sample of 175 terminals and glial profiles in 
the VCN and DCN. Gold particles were visually counted 
and the perimeter of each profile was traced on a digitizing 
tablet attached to a video display system and microcom- 
puter [ Summagraphic digitizing tablet, Dage-MTI Preci- 
sion 81 video camera and monitor, ZEOS computer], which 
calculated the surface area of the profile and density of its 
gold particles (expressed as number of gold particles/pm2 of 
profile) with software designed in-house. Statistical compari- 
sons were made by means of ANOVAs with Bonferroni’s 
correction for comparisons among multiple groups. 
Controls for the speci- 
ficity of the antibodies included incubation of sections in 
anti-GABA or anti-GLY conjugate preadsorbed with their 
respective antigens, which abolished all imrnunolabeling. 
Preadsorption of anti-GABA antibodies with GLY conju- 
gates or vice versa had no noticeable effect on the immuno- 
labeling. To evaluate the specificity of the immunogold 
detection method, ultrathin sections were incubated in 
PBS-Triton without the primary antibody, followed by the 
Quantitative comparisons. 
Immunocytochemical controls. 
tions showed abundant immunolabeling for GABA or GAD, 
and GLY in fibers and terminals throughout the CN 
neuropil and around most, if not all, neuronal cell bodies in 
this nucleus. GABA, GAD, or GLY immunolabeling was 
also shown in populations of neuronal cell bodies in the CN, 
which are far more numerous in the dorsal CN (DCN) than 
in the ventral CN (VCN) (Kolston et  al., 1992). The labeled 
cells are likely to be interneurons that give rise to part of 
the rich system of putative GABAergic or glycinergic syn- 
apses in the CN (Wenthold, 19911, although there are also 
indications that a substantial component originates from 
projection neurons located extrinsically in other auditory 
nuclei (Altschuler et al., 1993; Potashner et al., 1993; Saint 
Marie et al., 1993; Wickesberg and Oertel, 1993). 
Ultrastructural evaluation provides a degree of analysis 
in which GABA and GLY immunolabeling can be resolved 
to individual synaptic terminals (e.g., Altschuler et al., 
1986a, 19931, allowing the opportunity to better character- 
ize the patterns of GABAergic and glycinergic synaptic 
distribution on individual neurons. Several ultrastructural 
studies have assessed GAD, GABA, or glycine immunoreac- 
tivity at the ultrastructural level in the CN (Mugnaini, 
1985; Altschuler et al., 1986a, 1993; Wenthold et al., 1986, 
1987; Adams and Mugnaini, 1987; Oberdofer et al., 1988; 
Saint Marie et al., 1989). However, few studies have 
examined and compared the synaptic co-containment of 
GABA and GLY (Wenthold et  al., 1988; Altschuler et al., 
1993), and none surveyed the entire CN. Since most 
neuronal types tested so far in the CN are inhibited by 
GABA and GLY (Caspary, 1986; Caspary et  al., 1979,1985, 
1993), it is essential to study both transmitters in the same 
tissue. Rather than being spatially segregated, GABA and 
GLY immunoreactivities may coexist in some neuronal and 
terminal populations of the CN (Wenthold et al., 1987; 
Oberdorfer et al., 1987; Juiz et al., 1989a; Osen et a]., 1990; 
Kolston et  al., 19921, as well as in the cerebellum (Ottersen 
et al., 1988, 1990), superior olivary complex (Helfert et al., 
1992), and spinal cord (Triller et al., 1993a,b). Thus, it is 
important to categorize the different types of GABA/GLY 
terminals in an  ultrastructural evaluation of these amino 
acid transmitters in the CN in order to better predict their 
functional roles. 
Therefore, we sought to analyze and compare the synap- 
tic distribution of GABA and GLY immunoreactivities in 
the CN. To accomplish this goal we have used ultrastruc- 
tural postembedding immunogold immunocytochemistry 
on adjacent pairs of ultrathin sections, labeled sequentially 
to detect GABA or GLY immunoreactivity in the same 
synaptic structure. The use of the immunogold technique 
makes it possible to make semiquantitative comparisons of 
the localization of these amino acids in the different neural 
compartments in the CN. 
MATERIALS AND METHODS 
The care and use of animals in this study was approved 
and supervised by the University of Michigan Unit on 
Laboratory Animal Medicine. Eight adult, pigmented guinea 
pigs (250-350 g) with normal pinna reflexes were used in 
this study. They were deeply anesthetized with an  intraperi- 
toneal injection of sodium pentobarbital (75 mg/kg) and 
perfused transcardially with 3% paraformaldehyde and 
0.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 
7.35). Each animal received 600 to 800 ml of fixative at a 
rate of 50 to 70 ml/min. The brainstem was removed and 
immersed in the same fixative for 2 to 4 hours at 4°C 
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secondary antibody labeled with colloidal gold. No immuno- 
gold labeling was found in the absence of primary antibody. 
RESULTS 
Synaptic Distribution of GABA and GLY 
Immunolabeling Reveals Three Classes of 
Putative Inhibitory Endings in the  CN 
An analysis of the patterns of localization of GABA and 
GLY immunolabeling in synaptic endings of the CN re- 
vealed the existence of three different types of labeled 
endings. One type was characterized by high levels of GLY 
immunoreactivity (GLY endings). The second type pos- 
sessed intense GABA immunoreactivity (GABA endings) 
and the third type contained elevated levels of immunoreac- 
tivity for both GLY and GABA (GLYiGABA endings) (Fig. 
1). Semiquantitative evaluation of the density of gold 
particles over profiles of GLY, GABA, and GLYiGABA 
terminals confirmed these observations (Fig. 2). In GLY 
endings, immunoreactivity for GLY was 14 times higher 
than that in glia, while GABA immunolabeling was essen- 
tially indistinguishable from glial levels (Fig. 2A). In GABA 
endings, GABA immunoreactivity was, on average, 12 
times higher than in glia (Fig. 2B). In GLYiGABA endings, 
the average densities of both GLY and GABA immunolabel- 
ing were substantially higher than in glia (7 and 6 times 
respectively) but interestingly, only half that found for GLY 
in GLY endings and GABA in GABA endings (Fig. 2C). In a 
fourth class of endings encountered in the CN, the densities 
of GLY and GABA immunoreactivities were indistinguish- 
able from glial labeling (Fig. 2D). 
Characteristics and General Distribution 
of GLY, GABA, and GLY/GABA Endings 
in the  CN 
Regardless of location in the CN, glycine, GABA, and 
GLYiGABA endings shared two major morphological fea- 
tures. All three types contained pleomorphic vesicles and 
were always characterized by symmetric synaptic densities 
(Figs. 3, 4, 5 ,  6). In fact, all endings with pleomorphic 
vesicles and symmetric synaptic densities evaluated were 
immunolabeled with a t  least one of the two antibodies. 
Besides electron-lucent, pleomorphic synaptic vesicles, it 
was not uncommon to find scattered dense-core vesicles in 
the three classes of putative inhibitory endings, particularly 
in AVCN, and overall, in GABA endings (Fig. 1). On the 
other hand, the vast majority of unlabeled endings con- 
tained larger, homogeneously round synaptic vesicles, and 
asymmetric synaptic densities (Figs. 1, 5 ,  9). 
Some relevant observations regarding the size of the 
three types of endings deserve mention. First, the smallest 
endings were consistently of the GABA type. These endings 
averaged 0.7 pm in diameter, and rarely exceeded 1.5 pm. 
Second, GLY and GLYiGABA endings had an average size 
of 1.5 and 1.6 km respectively. However, considerable 
variations in size were observed especially among GLY/ 
GABA endings. Endings of this class as large as 4.5 pm 
were found in the DCN, and in general it appeared that 
larger-sized, labeled endings were more common in the 
DCN (Figs. 7,8). 
Differences were noted in the relative occurrences of 
GLYIGABA, GLY, and GABA terminals. GABA endings 
were the least common type both in VCN and DCN, and 
GLY endings appeared to be more abundant than GLY/ 
GABA endings in VCN, particularly in the caudal part of 
the posteroventral CN (PVCN). However, in DCN the 
GLYiGABA ending was the type most frequently observed. 
Patterns of distribution of GLY, GABA, and GLYIGABA 
endings were assessed on the perikarya and proximal 
dendrites of four major types of CN projection neurons, 
including spherical bushy and stellate multipolar cells in 
the anteroventral CN (AVCN), octopus cells in PVCN, and 
fusiform cells in DCN. These cell types were identified 
using ultrastructural criteria established by several previ- 
ous studies (spherical bushy cells: Schwartz and Gulley, 
1978; Oberdorfer et al., 1988; Wenthold et al., 1988; stellate 
multipolar cells: Cant 1981; Smith and Rhode, 1989; Saint 
Marie et al., 1993; octopus cells: Kane, 1973, 1977; Moore, 
1986, Wenthold et  al., 1988; Kolston et al., 1992; fusiform 
cells: Kane, 1974; Smith and Rhode, 1985). Perhaps the 
most striking patterns were those encountered on the 
somata of spherical bushy cells in the rostra1 AVCN, on 
which immunolabeled endings were typically organized in 
distinct clusters (Figs. 3,lO). These clusters contained from 
two to six immunolabeled endings, and were interposed 
between the larger, unlabeled terminals of the auditory 
nerve (Fig. 10). A distinct envelope of astrocytic processes 
wrapped each cluster (Fig. 3). GLY endings clearly predomi- 
nated, although they always coexisted with GLYiGABA 
and GABA endings (Fig. 10). On the primary dendrites, 
however, immunolabeled terminals were frequently packed 
together, although they did not form distinct clusters. This 
was also the case in the neuropil surrounding spherical 
bushy cell bodies. 
The pattern of organization of GLY, GLYIGABA, and 
GABA endings on spherical bushy cell bodies was in sharp 
contrast to that typically observed on type I stellate multipo- 
lar cells where, sometimes only one or two small GLY or 
GABA endings, contacted each somal profile (Fig. 10). 
Axo-somatic GLYiGABA endings were uncommon. How- 
ever, the primary dendritic trunks of the stellate multipolar 
cells were apposed by an abundance of GLY, GLYIGABA, 
and GABA endings. These endings were not arranged in 
clusters. The perikarya of octopus cells were contacted by 
an abundance of GLY and unlabeled endings (Figs. 6, 10) 
and a few GABA endings (Fig. 10). However, GLYiGABA 
endings were uncommon, and the cluster-like organization 
of the inhibitory-type terminals was not as obvious as in the 
spherical bushy cells. 
On the perikarya of fusiform cells, the GABA and GLYi 
GABA endings were most frequently observed and were 
distributed in irregular groups around each somal profile, 
with long stretches of somatic membrane receiving no 
synaptic contact (Figs. 7,lO). GLYiGABA endings predomi- 
nated on the trunks of basal and apical dendrites (Fig. 8). In 
the neuropil of the fusiform cell layer, most of the axoden- 
dritic synaptic terminals corresponded to roughly equal 
proportions of GLY and GLYiGABA endings, particularly 
in its deeper portions, and were usually found in close 
proximity to the less numerous, large unlabeled endings of 
the auditory nerve. The three classes of putative inhibitory 
endings also contacted the shafts of spiny dendrites in the 
molecular layer presumably associated with the dendritic 
arbors of fusiform or cartwheel cells (Fig. 9). Most spines 
received unlabeled synaptic boutons containing round 
vesicles (Fig. 9). However, no clear trend could be estab- 
lished for the predominance of a single class of immunola- 
beled ending on these dendrites. 
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Fig. 1. Glycine (GLY) and y-amino butyric acid (GABA) immunore- 
tivities in synaptic terminals of the anteroventral cochlear nucleus 
.VCNJ. This picture illustrates three types of irnmunoreactive termi- 
11s found on serial ultrathin sections of the AVCN incubated with 
LY (top) or GABA (bottom) antibodies, by using an  immunogold label. 
iree immunolabeled terminals (1, 2, 3)  contact the somata of a 
hericalibushy cell (sph). One (1) contains both GLY and GABA 
Imunoreactivities. Adjacent to this, a second terminal (21 is immuno- 
reactive only for GLY. A third one, small and with several dense-core 
vesicles (31 immunolabels only for GABA. A primary afferent terminal 
(pa) shows only background levels of GLY immunoreactivity. Similar 
types of immunoreactive terminals are found in the neuropil(4,5,6, 71: 
GLYiGABA (4, 5, arrows), GLY (6) ,  or GABA (71. A large unlabeled 
terminal (pa)  containing large round vesicles makes an axo-dendritic 
contact. Scale bar = 500 nm. 
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Glycine and GABA lmmunoreactivities 
in Synaptic Terminals of the CN 
A B 
I c = GLY~GABA terminals 
D = Non GLYiGABA terminals 
E = Glia 
. . . _ ~ ~ ~ _ ~ ~  
C D E 
0 = Glycine density Terminal Type = = GABA density 
Fig. 2 .  Mean densities of immunogold labeling (gold particles/ 
square micron) for GLY and GABA in synaptic endings (Lanes A, B, C, 
D) and glia (Lane E) in the CN. Differences in GLY immunolabeling in 
A, GABA immunolabeling in B, and GLY and GABA immunolabeling in 
DISCUSSION 
The present study focuses on the synaptic localization 
and colocalization of the inhibitory amino acids GLY and 
GABA in the CN in order to further characterize the 
inhibitory-type synaptic endings and describe their pat- 
terns of distribution on the various types of CN projection 
neurons. Colocalization of GABA and GLY has been re- 
ported previously in neuronal populations of the CN using 
light microscopic immunocytochemistry (Wenthold et  al., 
1987; Oberdofer et al., 1988; Juiz et al., 1989a; Moore and 
Osen, 1990; Osen et  al., 1990, 1991; Kolston et al., 1992). 
Our findings confirm and expand these observations, dem- 
onstrating directly the presence in the CN of synaptic 
endings containing increased levels of both GLY and GABA 
immunoreactivities. The major conclusions to be derived 
from this work are that three populations of inhibitory 
amino acid immunoreactive endings exist in the CN, each 
containing either one or both amino acids, and that these 
terminal classes are differentially distributed on the cell 
types studied. Taken together, these findings add further 
support to the extensive evidence indicating a major neuro- 
transmitter role for GLY and GABA in non-primary syn- 
apses of the CN (reviewed by Wenthold and Martin, 1984; 
Caspary, 1986; Wenthold, 1991. See also, Altschuler et  al., 
1993; Potashner et al., 1993; Saint Marie et  al., 1993). 
All three classes of terminals revealed by GABA and GLY 
immunoreactive staining share the morphology classically 
associated with putative inhibitory synapses (Uchizono, 
1965; Pappas and Waxman, 19721, i.e., the presence of 
pleomorphic vesicles and symmetric pre- and postsynaptic 
densities. In the CN, these ultrastructural characteristics 
are common to the majority of non-cochlear nerve (non- 
primary) synapses (Lenn and Reese, 1966; Kane, 1977; 
Schwartz and Gulley, 1978; Cant and Morest, 1979; Tolbert 
and Morest, 1982; Altschuler et al., 1986a). Further distinc- 
tion of non-cochlear endings as containing either oval/ 
C relative to D and E were statistically significant (P  < 0.001). The 
lower immunolabeling density for both GABA and GLY in C relative to 
levels in A and B also was statistically significant ( P  < 0.01). Vertical 
bars represent S.E.M. See text for further details. 
pleomorphic or flattened vesicles (Schwartz and Gulley, 
1978; Cant and Morest 1979; Tolbert and Morest, 1982; 
Smith and Rhode, 1985; Altschuler et  al., 1986a; Wenthold 
et al., 1988) could not be made in our material, probably 
because of differences in fixation conditions (Valdivia, 
1971). However, the generic classification of ‘pleomorphic 
vesicles‘ (Wouterlood and Mugnaini, 1984; Mugnaini, 1985; 
Adams and Mugnaini, 1987) assigned to the three classes of 
immunolabeled endings sufficed to distinguish them from 
endings with uniformly round, synaptic vesicles and more 
asymmetric synaptic contacts. These synaptic endings, 
many of which represent primary input from the auditory 
nerve (Lenn and Rees, 1966; Kane, 1977; Schwartz and 
Gulley, 1978; Cant and Morest 1979; Tolbert and Morest, 
1982) were never labeled above background for GLY or 
GABA. 
Unlabeled endings with the ultrastructural characteris- 
tics described above were not observed, suggesting that all 
inhibitory synapses in the CN probably utilize GLY and/or 
GABA as neurotransmitters. Indeed, that virtually all 
putative inhibitory endings can be classified as GLY, GABA, 
or GLYiGABA is a significant departure from previous 
studies on the localization of inhibitory amino acids in CN 
synaptic endings, most of which have dealt with the distri- 
bution of GAD or GABA immunoreactive endings (Mug- 
naini, 1985; Shiraishi et al., 1985; Adams and Mugnaini, 
1987; Oberdorfer et al. 1988; Saint Marie et  al., 1989). In 
the above studies, substantial numbers of unlabeled non- 
cochlear endings, most probably corresponding to the GLY 
endings described in this study, were found along with 
those immunolabeled for GAD or GABA. Therefore, it may 
be possible to assign GLY and/or GABA to virtually all 
anatomically-defined ‘inhibitory‘ endings in the CN. This 
does not preclude, however, the presence of additional 
neuroactive substances in these synaptic endings. In fact, 
dense core vesicles typically associated with neuropeptides 
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Fig. 3 .  Three immunoreactive terminals contactinga spherical cell body (sph) in the rostra1 AVCN. Two 
of them (1, 2)  contain both GLY and GABA immunoreactivities. The third is immunolabeled only for GLY 
( 3 ) .  Note that the three terminals are closely packed. They are part of a cluster of synaptic endings, whose 
glial wrapping is indicated by arrowheads. Scale bar = 250 nm. 
>r catecholamines (Cooper et al., 1985) were observed in 
many of the immunoreactive terminals, particularly GABA 
immunopositive endings in the AVCN. Colocalization of 
SABA and neuropeptides has been described in periolivary 
and deep DCN neurons that probably project to the VCN 
(Adams, 1993). Also, Vetter et al. (1993) have reported 
choline acetyltransferase immunoreactivity in some end- 
ings with pleomorphic vesicles and symmetric densities in 
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Fig. 4. GLY immunoreactive ending on the somata of a globular bushy cell (glob) the in caudal AVCN. 
The synaptic area is grazed by the section (arrows), and partially includes a somatic spine. The opposite side 
of the spine makes contact with an unlabeled primary afferent (pa). Scale bar = 1 pm. 
the CN, thus leaving open the possibility of colocalization of 
acetylcholine with GABA and/or GLY. 
While data from many other studies strongly support 
synaptic release of GLY and GABA in the CN, they leave 
unresolved the question of whether both amino acids may 
be released from the same terminal, as suggested here by 
the presence of the large population of GLYiGABA endings. 
There is some evidence from research in other areas of the 
brain suggesting that both amino acids might represent 
neurotransmitter pools in GLYiGABA endings. Studies on 
purified synaptic vesicles from brainstem and spinal cord 
(Christensen et al., 1990; Burger et al., 1991) indicate the 
existence of a shared transporter mechanism for the vesicu- 
lar uptake of GABA and GLY. Ottersen and coworkers 
( 1988) not only observed colocalization of GLY and GABA 
immunoreactivities in Golgi cell endings in the rat cerebel- 
lum, they also suggested that GLY and GABA are core- 
leased by demonstrating the elimination of both GLY and 
GABA immunoreactivities from Golgi cell endings, which 
occurred only in the presence of calcium upon potassium- 
induced depolarization of cerebellar slices (Ottersen et al., 
1990). In view of its abundance of GLYiGABA endings, 
it would be interesting to replicate these experiments in 
the CN. 
In the present study, quantitation of the relative num- 
bers of immunolabeled endings was not attempted. How- 
ever, it was obvious that in general GLY/GABA endings 
outnumbered GABA endings and matched roughly the 
abundance of GLY endings. The abundance of GLYiGABA 
endings may indicate the magnitude of their functional 
contributions. If it is confirmed that both amino acids are 
synaptically released from GLYiGABA endings, then the 
present findings would predict that a substantial amount of 
GABA available for inhibition in the CN coexists with GLY. 
As discussed above, however, this coexistence is not re- 
stricted to the CN; thus, it may have widespread functional 
relevance. 
The specific inhibitory actions of GLY, GLYIGABA, and 
GABA endings would be determined in part by the type and 
localization of their associated receptors. Physiological/ 
pharmacological studies have shown that GLY and GABA- 
mediated inhibition of CN neurons is blocked by the 
antagonist of glycine and GABAA receptors, strychnine and 
bicuculline respectively (Caspary et al. 1979; Martin et al., 
1982; Martin and Dickson, 1983; Martin and Penix, 1983; 
Caspary, 1986; Caspary et al., 1993; Evans and Zhao; 1993). 
GLY-dependent, strychnine-sensitive inhibitory postsynap- 
tic potentials have been identified in the CN (Wu and 
Oertel, 1986; Oertel and Wickesberg, 1993). GLY and 
GABA receptors have been anatomically localized and 
mapped in the CN using receptor autoradiographic (Frost- 
holm and Rotter, 1986; Glendenning and Baker, 1988; Juiz 
et  al., 1994) and immunocytochemical methods (Altschuler 
et  al., 198613; Wenthold et al., 1988; Juiz et al., 1989b). At 
the synaptic level, immunoreactivity for the 93 Kd GLY 
receptor-associated anchoring protein (gephyrin) has been 
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Fig. 5. Dendritic profile (den) in AVCN apposed by several synaptic 
terminals. One (large arrow) shows co-localization of GLY and GABA 
immunoreactivities. An adjacent one is immunoreactive only for GLY 
(small arrow). As in previous examples all these immunolabeled 
found postsynaptic to many endings containing pleomor- 
phic or flattened vesicles (Altschuler et  al., 1986b; Wen- 
thold et al., 1988; Altschuler et  al., 1993). In addition, 
experiments combining GAD and GLY receptor immunocy- 
tochemistry have shown GLY receptor immunoreactivity 
postsynaptic to GAD immunoreactive endings in the AVCN 
(Oberdorfer et al., 1987; Altschuler et al., 1993) and spinal 
cord (Triller et al., 1987). Although additional confirmatory 
double labeling studies need to be done, these findings 
indicate that both GLY and GLYIGABA endings are ap- 
posed to GLY receptors. 
Relationship to GLY and GABA Receptors 
in the CN 
The types and distributions of GABA receptors and their 
association with GABA immunolabeled endings in the CN 
is not yet clear. Results from receptor autoradiographic 
assays for low-affinity GABAA receptors (Frostholm and 
Rotter, 1986; Glendenning and Baker, 1988; Juiz et al., 
1994) and GABAB receptors (Juiz et  al., 1994) only par- 
tially overlap with the distribution of GABA immunoreactiv- 
ity in the CN. Similarly, antisera to the p subunit of the 
GABAA receptor labeled the postsynaptic areas beneath 
many synaptic endings containing pleomorphic vesicles in 
DCN, but very few in AVCN (Juiz et al., 1989b). The types 
ind distributions of GABA receptors apposing GABA and 
ZLYIGABA terminals in the CN need to be studied in 
greater detail. This is particularly important for receptors 
issociated with GLYiGABA terminals, because several 
terminals contain pleomorphic vesicles. The asterisk indicates an 
unlabeled ending with large round vesicles and asymmetric synaptic 
density, most probably from the auditory nerve. Scale bar = 500 nm. 
possibilities exist. Both GLY and GABA could act postsynap- 
tically on their respective receptors (reviewed by Triller et 
al., 1990). The subunits and configuration of the GABA 
receptor apposing GABAIGLY terminals may be different 
than that apposing GABA terminals. If this is the case then 
both antibodies used in immunocytochemical studies and 
the ligand in receptor binding studies could bind with less 
affinity. Since GABAiGLY terminals make up the majority 
of the GABA containing terminals in VCN, it could explain 
the low binding and immunocytochemical staining in VCN. 
GABA might also act presynaptically to suppress transmit- 
ter release. Finally, the possibility exists for allosteric 
modulations of GLY receptors by GABA (Werman, 1980; 
Faber and Korn, 1991). 
Patterns of GLY and GABA Input 
on Major Cell Types in the CN 
Although a detailed analysis of the spatial distribution of 
GLY, GABA, and GLYiGABA endings was beyond the 
scope of this study, a number of observations were made on 
the distribution of immunolabeled endings on the cell 
bodies of four major types of CN neurons. Cell-specific 
patterns of synaptic inputs, probably reflecting differences 
in function, have been described previously in the CN 
(Brawer et  al., 1974; Kane, 1977; Cant and Morest, 1979; 
Smith and Rhode, 1985; Adams and Mugnaini 1987; Kols- 
ton et al., 1992), and the present results support and extend 
these observations. 
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Fig. 6. Serial sections immunostained for GLY and GABA showing 
two typical endings on the cell body of an octopus cell (oct) which are 
immunoreactive only for GLY (large arrows in GLY). Notice the small 
unlabeled terminal (asterisk). Scale bar = 500 nm. 
Clusters of non-primary endings have been described on 
the somata of spherical bushy cells (Cant and Morest, 1979, 
Saint Marie et al., 1989; Ostapoff and Morest, 1991; Saint 
Marie et al., 19931, some containing GAD or GABA immu- 
noreactivities (Adams and Mugnaini, 1987; Oberdorfer et 
al., 1988; Saint Marie et al., 1989, 1993). In our material, 
the vast majority of the endings in these clusters contained 
GLY, GABA, or both, with GLY endings prevailing and 
GABA terminals the least common. In addition, each 
cluster was covered by an envelope of glial processes. 
Perhaps by acting as a diffusion barrier, this glial envelope 
may limit the movement of GLY and GABA away from the 
underlying synaptic zones, thus enhancing their inhibitory 
effect. Consistent with these findings, both GABA and GLY 
appear to produce effective inhibition within the excitatory 
response area of primary-like and phase-locked units in 
AVCN, with the GLY effects being slightly more intense 
than those of GABA (Caspary et al., 1993). The clusters 
were always situated near unlabeled auditory nerve end- 
ings, which were only occasionally embraced by the same 
glial processes delimiting the 'inhibitory cluster.' However, 
although GLY and GLYiGABA endings prevailed on the 
primary dendrites and, in general, in the neuropil surround- 
ing sphericalibushy cell bodies, they were not organized in 
distinct clusters. 
Contrary to spherical bushy cells, type I stellate multipo- 
lar cells in the AVCN receive sparse axosomatic synaptic 
input (Cant, 1981; Oberdorfer et al., 1988; Wenthold et al., 
1988; Smith and Rhode, 1989; Saint Marie et al., 1993). We 
found that the few non-cochlear axosomatic terminals 
immunolabeled either for GLY or GABA, but not both. 
Indeed, GLY receptor immunoreactivity has been observed 
apposing axosomatic terminals in stellate multipolar cells 
(Wenthold et al., 1988). Whenever the primary dendrite of a 
stellate multipolar cell was identified, it appeared that they 
were contacted predominantly by GLY endings. However, a 
complete picture of inhibitory input on stellate multipolar 
cells cannot be obtained without a thorough description of 
the distribution of GLY and GABA terminals on their 
extensive dendritic trees. Intracellular labeling combined 
with ultrastructural immunocytochemistry will be espe- 
cially useful to address the spatial organization of putative 
inhibitory endings on this cell type. 
Octopus cell bodies were contacted largely by GLY and, to 
a lesser extent, by GABA endings. Similar to stellate 
multipolar cell bodies, GLYiGABA endings were rarely 
found. The immunolabeled endings did not form distinct 
clusters, Instead, they tended to be isolated and evenly 
distributed around the soma. It is generally agreed that 
GAD immunoreactive endings on octopus cell bodies are 
sparse and evenly distributed (Adams and Mugnaini, 1987; 
Saint Marie et al., 1989). Kolston et al. (1992) have 
described relatively abundant GLY endings on octopus cells 
in guinea pig, while Wickesberg and Oertel (1991, 1993) 
report less abundant endings on octopus cells in the mouse. 
A major characteristic of DCN fusiform cells was the 
predominance of immunolabeled terminals over unlabeled 
endings. The abundance of GLYiGABA and GABA endings 
on the cell body and, in the case of GLYiGABA terminals 
the primary apical and basal dendritic trunks as well, 
suggests a fundamental role for these endings in the 
regulation of excitation at the level of the cell body. On the 
other hand, the large proportion of GLY and GLYiGABA 
axodendritic endings in the neuropil of the fusiform cell 
layer and their proximity to unlabeled endings of the 
auditory nerve indicate that both types of endings may 
control the spread of primary afferent excitation along the 
dendrites. These findings are consistent with light and 
electron microscopic observations on the morphology and 
distribution of GLY and/or GABA immunoreactive puncta 
in the DCN (Kane, 1977; Wouterlood and Mugnaini, 1984; 
Mugnaini, 1985; Smith and Rhode, 1985; Kolstan et al., 
1992). 
Potential Origins of the GLY 
and GABA Inputs 
The precise origins of the different classes of GLY and/or 
GABA immunoreactive endings described in this study still 
remain to be fully explored. GLY and/or GABA immunore- 
active cell bodies have been described in the VCN (Wen- 
thold et al., 1986, 1987; Kolston et al., 1992). However, they 
are sparse, suggesting that the majority of GLY, GLYi 
GABA, and GABA endings originate outside this division. A 
major source of putative glycinergic input to the AVCN are 
GLY immunoreactive tuberculoventral or vertical cells in 
deep DCN (Cant and Morest, 1978; Lorente de No, 1981; 
Wickesberg and Oertel, 1988; Oertel and Wu, 1989; Saint 
Marie et al., 1991, 1993; Osen, 1990; Kolston et al., 1992; 
Fig. 7. Visualization of colloidal gold particles was enhanced in this 
figure. Electron microgaph negatives were digitized on a Leaf Scanner 
45 at  1060 pixelsiinch resolution. Colloidal gold particles were visual- 
ized and thresholded at  high magnification and were all replaced with 
larger dots using the pencil tool of Adobe Photoshop on a Power 
Macinstosh 8100/100 AV. The image was then printed on a Kodak XL 
8600 PS Printer. A: GLY and GABA immunoreactive terminals on a 
fusiform cell body (fus) and neuropil of the fusiform cell layer. 
Terminals 1,2, and 4 contain both GLY and GABA immunoreactivities. 
Terminal 5 is immunoreactive only for GLY. The small ending 3 is not 
immunolabeled. The asterisk also indicates an unlabeled ending. The 
elongated ending 2 is the most characteristic type of co-labeled terminal 
found in the fusiform cell layer. Note also the large size of co-labeled 
terminal 4 (arrow) compared with the size of dendrite it contacts. B: 
Two co-labeled terminals (large arrows) on a fusiform cell body (fus). 
The cross sectioned profile of an axon immunoreactive only for GLY i s  
also shown (small arrow ). Scale bars = 550 nm in A. 500 nm in B. 
Fig. 8. Visualization of colloidal gold particles was enhanced in this 
figure. Electron microgaph negatives were digitized on a Leaf Scanner 
45 a t  1060 pixels/inch resolution. Colloidal gold particles were visual- 
ized and thresholded at high magnification and were all replaced with 
larger dots using the pencil tool of Adobe Photoshop on a Power 
Macinstosh 81001 100 AV. The image was then printed on a Kodak XL 
8600 PS Printer. A: Thick dendrite in the deep fusiform cell layer, 
probably belonging to a fusiform cell. Several immunoreactive endings 
contact the unlabeled dendritic profile. 1 is GLY immunoreactive, 2 is 
unlabeled. 3 and 4 contain both GLY and GABA immunoreactivities, 
and 5 is immunreactivc only for GABA. Terminals such as  5 (open 
arrow) are the among the largest GABA terminals found throughout 
the cochlear nucleus. B: Neuropil of the upper fusiform layer. Two 
endings co-labeled for GABAand GLY are shown (arrows). One of them 
contacts the apical dendrite of a fusiform cell (den), which shows only 
background levels of immunogold labeling. This is the most abundant 
and characteristic type of immunolabeled terminal found on these 
dendrites. The second terminal is large, with a filamentous core and 
contacts a small caliber dendrite. Note the unlabeled terminal with 
large round vesicles (asterisk). Scale bars = 1 pni in A, 2 pm in B. 
Fig. 9. Montages from the molecular layer of the DCN showing a 
distal dendrite (den) of a cartwheel neuron, in which the visualization of 
colloidal gold particles was enhanced. A negative of the montage was 
digitized on a Leaf Scanner 45 at 1060 pixelsiinch resolution. Colloidal 
gold particles were visualized and thresholded at  high magnification 
and were all replaced with larger dots using the pencil tool of Adobe 
Photoshop on a Power Macinstosh 8100/100 AV. The enhanced image 
was then printed on a Kodak XL 8600 PS Printer. Note the prominent 
spines (arrowheads). Magnification is different in GLY and GABA. The 
dendrite contains GLY and GABA immunoreactivities. The asterisks 
indicate the most abundant terminal type found on these dendrites. 
These endings contact mainly spines but also dendritic shafts, contain 
large round vesicles and never immunolabel over background levels. 
Immunolabeled terminals generally contact dendritic shafts. In this 
example, two GLY immunoreactive endings are shown (arrows). Scale 
bars = 2 pm for GLY, 1 pm for GABA. 
Fig. 10. Composite drawings based on serial ultrathin sections of 
the cochlear nucleus immunostained for GLY and GABA. Four major 
cell types and the terminals apposing them are shown. Note the 
differences in the number, types, and distribution of the different 
terminal types among a spherical bushy cells (upper left), a type I 
stellate multipolar in the AVCN (upper right), an octopus cell in the 
PVCN (lower Icft), and a fusiform cell in the dorsal cochlear nucleus 
(DCN) (lower right). Sce text for further details. 
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Oertel and Wickesberg, 1993). These neurons may be a 
source of many GLY endings in AVCN, but not the only 
one. Only 50% of the GABA and GLY terminals on a typical 
globular bushy cell were found to originate in DCN (Altsch- 
uler et a]., 1993). Neurons projecting to the AVCN from the 
lateral and ventral nucleus of the trapezoid body as well as 
other periolivary cell groups are GLY and/or GABA immu- 
noreactive (Mugnaini and Oertel, 1985; Adams and Mug- 
naini, 1987; Ostapoff and Morest., 1991; Helfert et  al., 
1989; Saint Marie et al., 1993) or accumulate 13HjGLY or 
I3HIGABA upon injection in the CN (Potashner et al., 
1985; Staatz-Benson and Potashner, 1987, 1988; Benson 
and Potashner, 1990, Ostapoff et al., 1990; Potashner et al., 
1993). I t  has been reported that approximately one-third of 
periolivary cell bodies immunoreactive for GLY and GABA 
and projecting to the CN, stain for both GLY and GABA 
(Saint Marie et al., 1993). Therefore, periolivary cell groups, 
especially neurons in LNTB and VNTB, could be major 
sources of GLYIGABA, GLY, and GABA endings in AVCN. 
The same sources may be the origin of immunolabeled 
endings in PVCN. However, in the octopus cell area of this 
division, GLY endings probably do not originate from 
vertical cells in DCN (Wickesberg and Oertel, 1991, 1993). 
A pathway connecting the right and left cochlear nuclei has 
been reported to be glycinergic (Wenthold, 1987; Saint 
Marie et al., 1993). Less is known about inhibitory projec- 
tions from other auditory nuclei to the VCN (reviewed by 
Spangler and Warr, 19911, although the inferior colliculus 
does not seem to be involved in inhibitory projections to the 
CN (Ostapoff et  al., 1990; Saint Marie et al., 1993). Studies 
combining anterograde tract-tracing with ultrastructural 
immunocytochemistry will be necessary to unravel addi- 
tional sources of GLY, GLYIGABA, and GABA endings in 
the VCN. 
Contrary to VCN, many immunolabeled endings in the 
superficial DCN originate from local circuit interneurons. 
Cartwheel cells (Brawer et al., 1974; Wouterlood and 
Mugnaini, 1984; Mugnaini, 1985; Moore, 1986) are neurons 
preferentially located in the superficial portions of the 
fusiform cell layer, whose axons arborize and terminate in 
the superficial DCN (Oertel and Wu, 1989). Cartwheel cell 
somata stain for both GABA and GLY (Mugnaini, 1985; 
Wenthold et al., 1986; Oberdorfer et al., 1987; Wenthold et  
al., 1987; Kolston et  al., 1992). Synaptic endings of cart- 
wheel cells labeled with an  antibody against a cell-specific 
peptide (Berrebi and Mugnaini, 1991) have patterns of 
distribution very similar to our GLYiGABA endings. I t  is 
therefore very likely that a large proportion of GLYIGABA 
endings in DCN originate from cartwheel cells. Another 
source of GLYiGABA endings may be Golgi cells (Mugnaini 
et al., 1980), which were recently shown to stain for both 
GABA and GLY (Kolston et  al., 1992). As mentioned above, 
most vertical cell bodies in deep DCN label exclusively for 
GLY (Saint Marie et al., 1991; Kolston et al., 1992). Axon 
collaterals of these neurons arborize extensively in the 
fusiform cell layer (Wu and Oertel, 1986). Therefore, at  
least part of the GLY endings in DCN seemingly arise from 
vertical cells. Less information is available about the pos- 
sible origins of GABA endings, although some may arise in 
the molecular layer from stellate cells that immunostain for 
GAD or GABA (Wouterlood et al., 1984; Mugnaini, 1985; 
Kolston et a]., 1992). However, despite evidence indicating 
a large proportion of GLY, GLYIGABA, and GABA endings 
originating from intrinsic neurons, the contribution of 
extrinsic sources to inhibitory terminals in the DCN is 
probably substantial as well and needs to be studied in 
detail. There are important projections to the DCN from 
periolivary nuclei, nuclei of the lateral lemniscus, and 
inferior colliculi (reviewed by Spangler and Warr, 1991) and 
there is evidence, at least for periolivary cell groups, that 
some of these descending projections may use GLY and/or 
GABA as transmitters (Benson and Potashner, 1990; 
Ostapoff et  al., 1990; Potashner et al., 1993; Saint Marie 
et  al.. 1993). 
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